Literature DB >> 10595385

[Prenatal diagnosis of heart defects and associated chromosomal aberrations].

R Chaoui1, H Körner, C Bommer, B Göldner, A Bierlich, R Bollmann.   

Abstract

AIM: According to epidemiological studies on newborns, the association of congenital heart defects with chromosomal anomalies varies between 4 and 12%. Prenatally this rate is probably higher, due to antenatal death occurring in fetuses with chromosomal aberrations. The aim of the study was therefore to determine the rate and the distribution of chromosomal aberrations in prenatally detected heart defects. PATIENTS AND
METHOD: Within a period of 7 years fetal echocardiography was performed on 2716 fetuses at high risk for CHD. The analysis of the fetal heart was achieved by the visualization of different planes. Once a heart defect was detected, karyotyping was performed after amniocentesis, cordocentesis or chorion villous sampling, or in a few cases postnatally from cord blood. Prenatal ultrasound findings were confirmed postnatally by ultrasound examination or, in case of abortion, stillbirth or neonatal death, by autopsy.
RESULTS: A total of 203 fetal heart malformations were detected and 46 of them (22%) had associated chromosomal anomalies. 60% of all cases and 80% of the study group had extracardiac anomalies. Only eight out of the 46 pregnant women (17.5%) were older than 35 years. Eight out of the 15 fetuses with trisomy 18 had a ventricular septal defect, 9/13 fetuses with trisomy 21 had an atrioventricular septal defect and all 5 fetuses with monosomy X had a left heart outflow obstruction. No typical cardiac defects were found in the remaining 13 fetuses (5 trisomy 13, 2 triploidies, 6 miscellaneous). Of the 13 live births (23 terminations of pregnancy and 10 intrauterine deaths) 6 children survived (46% and overall survival rate 13%). The following rates of associations with aneuploidies were found: atrioventricular septal defect 55%, ventricular septal defect and aortic coaction both 43%, tetralogy of Fallot and double outlet right ventricle both 36%. In comparison, fetuses with isomerism, transposition of the great arteries and pulmonary atresia or stenosis had normal chromosomes.
CONCLUSION: We conclude that the rate of association of heart defects and chromosomal abnormalities is higher prenatally than in the neonatal period and is approximately 22%. After detecting a fetal cardiac malformation, karyotyping is mandatory for the further management of pregnancy. The likelihood of detection of an aneuploidy increases when some typical heart defects are detected or when an association with extracardiac anomalies is found.

Entities:  

Mesh:

Year:  1999        PMID: 10595385     DOI: 10.1055/s-1999-8912

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  5 in total

Review 1.  Genetic and Developmental Basis of Cardiovascular Malformations.

Authors:  Mohamad Azhar; Stephanie M Ware
Journal:  Clin Perinatol       Date:  2016-03       Impact factor: 3.430

2.  Investigating 22q11.2 deletion and other chromosomal aberrations in fetuses with heart defects detected by prenatal echocardiography.

Authors:  Fernanda Teixeira da Silva Bellucco; Sintia Iole Nogueira Belangero; Leila Montenegro Silveira Farah; Maria Virgínia Lima Machado; Adriano Pastor Cruz; Lílian Maria Lopes; Marco Antonio Borges Lopes; Marcelo Zugaib; Mirlene Cecília Cernach; Maria Isabel Melaragno
Journal:  Pediatr Cardiol       Date:  2010-09-17       Impact factor: 1.655

Review 3.  Cytogenomic Aberrations in Congenital Cardiovascular Malformations.

Authors:  Mahshid Azamian; Seema R Lalani
Journal:  Mol Syndromol       Date:  2016-04-26

4.  Fetal congenital heart disease: Associated anomalies, identification of genetic anomalies by single-nucleotide polymorphism array analysis, and postnatal outcome.

Authors:  Meiying Cai; Hailong Huang; Linjuan Su; Na Lin; Xiaoqing Wu; Xiaorui Xie; Gang An; Ying Li; Yuan Lin; Liangpu Xu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Rationale for the Cytogenomics of Cardiovascular Malformations Consortium: A Phenotype Intensive Registry Based Approach.

Authors:  Robert B Hinton; Kim L McBride; Steven B Bleyl; Neil E Bowles; William L Border; Vidu Garg; Teresa A Smolarek; Seema R Lalani; Stephanie M Ware
Journal:  J Cardiovasc Dev Dis       Date:  2015-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.